12 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
this therapy to patients world-wide,” said Giuseppe Accogli, Group CEO of Chiesi. “Gossamer shares Chiesi’s commitment to using innovation to promote the health
10-K
i46dg
22 Mar 19
Annual report
4:45pm
424B4
a21lr2
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
gzvkb7f4w
23 Jan 19
IPO registration (amended)
4:39pm
S-1
9wg1yfp82jx
21 Dec 18
IPO registration
4:39pm
DRS/A
ehzzmxcpjnbkn28
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
1exh a8nt0o35lr
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next